Split History
COGT split history picture
Cogent Biosciences (COGT) has 1 split in our COGT split history database. The split for COGT took place on November 09, 2020. This was a 1 for 4 reverse split, meaning for each 4 shares of COGT owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 250 share position following the split.

When a company such as Cogent Biosciences conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the COGT split history from start to finish, an original position size of 1000 shares would have turned into 250 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Cogent Biosciences shares, starting with a $10,000 purchase of COGT, presented on a split-history-adjusted basis factoring in the complete COGT split history. COGT split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 03/29/2018
End date: 06/14/2021
Start price/share: $44.44
End price/share: $9.11
Dividends collected/share: $0.00
Total return: -79.50%
Average Annual Total Return: -38.93%
Starting investment: $10,000.00
Ending investment: $2,049.82
Years: 3.21
Cogent Biosciences is a biopharmaceutical company focused on developing curative cell therapies for solid tumors. Co.'s proprietary technology includes its Bolt-On Chimeric Receptor platform, designed to discover bolt-on transgenes to improve the functionality of engineered T cells and overcome resistance of the solid tumor microenvironment to T cell attack. Co. has also developed product candidates using its proprietary technology, Antibody-Coupled T cell Receptor, an autologous engineered T-cell investigational therapy that is designed to combine the cell-killing ability of T cells and the tumor-targeting ability of co-administered antibodies to exert antitumor immune responses. According to our COGT split history records, Cogent Biosciences has had 1 split.
Date Ratio
11/09/20201 for 4
COGT is categorized under the Industrials sector; below are some other companies in the same sector that also have a history of stock splits:

CP Split History
CPRT Split History
CPST Split History
CR Split History
CREG Split History
CRRC Split History
CSS Split History
CSX Split History
CTAS Split History
CTS Split History

Also explore: COGT shares outstanding history

CSX Corporation (CSX)
Novan, Inc. (NOVN)
Castor Maritime Inc. (CTRM)
TrustCo Bank Corp NY (TRST)
Onconova Therapeutics, Inc. (ONTX)
A. H. Belo Corporation (AHC)
Assertio Holdings, Inc. (ASRT)
NEOGEN Corporation (NEOG)
LM Funding America, Inc. (LMFA)
Foxby Corp. (XFXBX)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

COGT Insider Buying

COGT Split History | www.SplitHistory.com | Copyright © 2013 - 2021, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.